5AM Ventures VI L.P. 13D and 13G filings for CinCor Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-28 4:30 pm Sale |
2023-02-24 | 13D | CinCor Pharma, Inc. CINC |
5AM Ventures VI L.P. | 0 0.000% |
-4,937,646 (Position Closed) |
Filing |
| 2023-01-18 4:00 pm Purchase |
2023-01-08 | 13D | CinCor Pharma, Inc. CINC |
5AM Ventures VI L.P. | 4,937,646 11.300% |
600,000 (+13.83%) |
Filing |
| 2022-01-21 4:15 pm Purchase |
2022-01-11 | 13G | CinCor Pharma, Inc. CINC |
5AM Ventures VI L.P. | 4,337,646 11.900% |
4,337,646 (New Position) |
Filing |